MHELTHERA Presentations

Talks

2024

• Holger Stephan

Use photons to find tumours

6th International Caparica Conference on Chromogenic and Emissive Materials, Lisbon (Portugal), July 7 – 11, 2024

• Michael Bachmann

Universal modular CARs: From the idea to the clinical application

TOLERATE: 2^nd Progress Meeting, Antwerpen (Belgium), May 21-24, 2024

• Holger Stephan

The why and how of stealth nanoparticles

LIMNI Workshop: Advancing Healthcare Technologies, KU Leuven (Belgium), May 23, 2024

• Michael Bachmann

Universal modular CARs: From the idea to the clinical application

Champalimaud’s “TIL (Tumor Infiltrating Lymphocytes) for the Treatment of Patients with Solid Cancer Experts on Future Perspectives” combined with Advanced Therapy Medicinal Products (ATMPs): Regulation and GMP Manufacturing Basics, Lisbon (Portugal), April 24-26, 2024

• Jürgen Kogler

Development of multimodal FAPI-PET radiotracers for preoperative PET imaging and fluorescence-guided surgery

62. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin (DGN), Leipzig (Germany), April 10-13, 2024

• Michael Bachmann

Combinatorial theranostic targeting of tumors and the tumor microenvironment

7th Theranostic World Congress, Santiago (Chile), March 22-24, 2024

• Anja Feldmann

Theranostic target molecules for adapter CAR-T cell therapies

26. Jahressymposium Interdisziplinäre Gruppe for Labor und Durchflusszytometrie (IGLD), Leipzig (Germany), March 7, 2024

• Michael Bachmann

UniCAR-basierte Therapie CD123-positiver Leukämien (TurbiCAR)

Netzwerkveranstaltung des BMBF für geförderte Projekte der „Innovationen für die individualisierte Medizin“ und der „Translationsprojekte Personalisierte Medizin“. dbb forum, Berlin (Germany), February 6-7, 2024

2023

• Michael Bachmann

From Autoimmunity to adaptor CAR-T cells: Another “La”ve Story

Pädiatrische Hämatologie, Onkologie und Stammzelltransplantation Regensburg (Germany), December 20, 2023

• Michael Bachmann

Gated Targeting: A long way from the idea to functionality

Fraunhofer-Institut für Zelltherapie und Immunologie (IZI), Leipzig (Germany), December 11, 2023

• Liliana Loureiro

Cancer immunotheranostics using adaptor CAR technologies and target modules

2023 HZDR Science Conference, Dresden (Germany), November 15 – 16, 2023 

• Christin Neuber

FAP-gerichtete Target Module für die Radionuklid-Theranostik und UniCAR T‑Zell-Therapie

Arbeitsgemeinschaft Radiochemie/Radiopharmazie, 1. Jahrestagung der GRPW e. V., Bad Salzuflen (Germany), September 28 – 30, 2023 

• Jürgen Kogler

Development of FAPI-PET Radiotracers for bimodal imaging and fluorescent-guided surgery

Arbeitsgemeinschaft Radiochemie/Radiopharmazie, 1. Jahrestagung der GRPW e. V., Bad Salzuflen (Germany), September 28 – 30, 2023 

• Christin Neuber

FAP directed target modules for UniCAR T cell therapy and radionuclide-based tumour theranostics

European Association of Nuclear Medicine 2023, Vienna (Austria), September 09 – 13, 2023

• Larysa Baraban

Biodetection platforms based on the extended gate FETs

International Conference on Functional Nanomaterials and Nanodevices 2023, Warsaw (Poland), August 28 – 30, 2023

• Michael Bachmann

How to retarget immune cells for the treatment of cancer and infectious diseases: A 40-year journey from the idea to the clinic

Tumor immunology meets infectious diseases “TIMID”, Brandenburg (Germany), July 14, 2023

• Željko Janićijević

Biodetection platforms based on the extended gate FETs

Hengstberger Symposium on Bioelectronics: "mimicking and interfacing biological systems", Heidelberg (Germany), May 15 – 17, 2023

• Michael Bachmann

Modular CARs

Tumor immunology meets oncology “TIMO 2023”, Halle (Germany), April 20-22, 2023

• Anja Feldmann

Wie Dresdner Forschende Immunzellen gegen Krebs nutzen

SaxoCell Lecture, Dresden (Germany), February 10, 2023

2022

• Claudia Arndt

Mildred-Scheel-Nachwuchszentrum Dresden: allogene UniCAR T-Zellen zur Behandlung und Therapieüberwachung der akuten myeloischen Leukämie35

Deutschen Krebskongress 2022 (DKK 2022), Berlin (Germany), November 15, 2022

• Kellie Tuck

Innovative sensing technologies – from lanthanide-based complexes to fluorescent labelled peptides

Seminar, HZDR, Dresden (Germany), November 11, 2022

• Holger Stephan

Bimodal Chelating Systems for Molecular Imaging

Seminar, Kitakyushu University, Kitakyushu (Japan), October 12, 2022;

Seminar, Saga University, Saga (Japan), October 19, 2022

• Holger Stephan

Multifunctional Stealth Nanoparticles for Biomedical Applications

Seminar, Sophia University Tokyo (Japan), October 7, 2022;

Seminar, Kyushu University, Fukuoka (Japan), October 19, 2022

Seminar, The University of Tokyo, Tokyo (Japan), November 1, 2022

• Claudia Arndt

Breaking new ground - How CAR technology can change the landscape of cancer theranostics

Seminar Series, Central Clinical School, Monash University, Melbourne (Australia), October 14, 2022

• Liliana Loureiro

Driving modular CARs through solid tumours and their microenvironment - a new era in cancer immunotherapy

Seminar Series, Central Clinical School, Monash University, Melbourne (Australia), October 14, 2022

• Manja Kubeil

Radiopharmaceutical evaluation of bifunctional chelators and bioconjugates for tumour imaging and therapy

Seminar, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne (Australia), October 10, 2022;

Webinar lecture, Monash Biomedical Imaging, Melbourne (Australia), October 12, 2022;

Seminar, University of Queensland, Brisbane (Australia), October 13, 2022

• Claudia Arndt (Plenary Lecture)

CAR Technology Meets Theranostics – A New Era of Immunotheranostics for Hematological and Solid Tumors

Australian Society of Molecular Imaging (ASMI) Annual Meeting 2022, Melbourne (Australia), October 06 – 07, 2022

• Liliana Loureiro

Immunotheranostic target modules suitable for imaging and navigation of UniCAR T-cells to strike FAP-expressing solid tumours and their microenvironment

Australian Society of Molecular Imaging (ASMI) Annual Meeting 2022, Melbourne (Australia), October 6 – 7, 2022

• Manja Kubeil

A novel bispidine-based chelator for radiopharmaceutical applications

Australian Society of Molecular Imaging (ASMI) Annual Meeting 2022, Melbourne (Australia), October 6 – 7, 2022

• Ina Kopp

¹⁷⁷Lu- and ^225Ac-labelling bispidine conjugates targeting neuroendocrine tumors

FG Nuclear Chemistry of the German Society of Chemistry, Annual Meeting 2022, Bergisch Gladbach (Germany), October 04 – 06, 2022

• Ina Kopp

¹⁷⁷Lu-, ²²⁵Ac- and ¹¹¹In-labelled nonadentate bispidine ligands: synthesis, radiolabeling experiments and stability assays

TERACHEM 2022, Convention Center Bressanone (Italy), September 14-17, 2022

• Christin Neuber

FAP directed target modules are suitable for imaging and targeted radionuclide therapy of FAP-expressing solid tumours and their microenvironment

5th GyMIC Molecular Imaging Symposium, Leipzig (Germany), September 15 – 16, 2022

• Anja Feldmann

Theranostic Antibody- and CAR-based Platform Technology for Therapy and Imaging

Antibody Technologies and Therapeutics Conference, Monash University Prato Centre, Italy, September 11 – 14, 2022

• Liliana Loureiro

Driving UniCARs to successful immunotherapy of solid tumors expressing fibroblast activation protein (FAP)

Antibody Technologies and Therapeutics Conference, Monash University Prato Centre (Italy), September 11 – 14, 2022

• Claudia Arndt

Engineered T-Cells for personalized cancer therapy

Precision Oncology Symposium, MSNZ, CRTD, Dresden (Germany), June 15, 2022

• Michael Bachmann (Chair and Lecturer)

Playing Boolean Algebra with CAR T cells: Why and How

International LIT Symposium “Synthetic Immunology / Synthetic Biology”, Regensburg (Germany) June 2022

• Michael Bachmann

Gated Targeting with CAR-T Cells

7th Lithuania International Hematology Oncology Colloquium, Kaunas (Lithuania), May 26, 2022

• Michael Bachmann (Chair and Lecturer)

INCREASING THE SAFETY OF CAR TECHNOLOGY: GATED TARGETING WITH MODULAR CARS

The 3rd International Conference on lymphocyte engineering 2022 (ICLE), Munich (Germany), March 31 – April 02, 2022

• Anja Feldmann

ADAPTOR UNICAR AND REVCAR PLATFORMS FOR FLEXIBLE, SWITCHABLE AND COMBINATORIAL TUMOR TARGETING

The 3rd International Conference on lymphocyte engineering 2022 (ICLE), Munich (Germany), March 31 – April 02, 2022

• Liliana Loureiro

AS SMALL AS IT CAN BE: SHORT PEPTIDE-DERIVED TARGET MOLECULES FOR REDIRECTION OF UNICAR T-CELLS AND IMAGING OF SSTR2-EXPRESSING CANCERS

The 3rd International Conference on lymphocyte engineering 2022 (ICLE), Munich (Germany), March 31 – April 02, 2022

Poster

2023

• Manja Kubeil

Bispidine - One chelator to bind lutetium-177 and actinium-225

25th International Symposium on Radiopharmaceutical Sciences (iSRS), Honolulu (Hawaii), May 22 – May 26, 2023

2022

• Claudia Arndt (3min ePoster Presentation)

UNICAR CAR T CELL THERANOTICS FOR DIAGNOSTIC IMAGING AND THERAPY OF PROSTATE CANCER

The 3rd International Conference on lymphocyte engineering 2022 (ICLE), Munich (Germany), March 31 – April 02, 2022